Current pharmacological management of anorexia in cancer patients.
Cancer cachexia is one of the most prevalent and devastating syndromes associated with advanced cancer. Its main clinical manifestation is profound anorexia. Progestational drugs have shown meaningful effects on appetite, food intake, and nutritional status in patients with advanced cancer and AIDS, and could be useful in managing anorexia. Corticosteroids also seem to produce increased appetite, but these effects are short-lived. Cyproheptadine, hydrazine sulfate, and cannabinoids also are being studied in the management of cancer-induced anorexia, but their role has not yet been clearly established. Future research should evaluate how the different drugs affect specific symptoms associated with cachexia.
Bruera
E
E
Palliative Care Unit, Edmonton General Hospital, University of Alberta, Canada.
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002100:Cachexia / Q000188:drug therapy*; D002186:Cannabinoids / Q000627:therapeutic use; D003533:Cyproheptadine / Q000627:therapeutic use*; D006801:Humans; D006834:Hydrazines / Q000627:therapeutic use*; D009369:Neoplasms / Q000150:complications*
D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D002186:Cannabinoids; D006834:Hydrazines; C029424:hydrazine; D003533:Cyproheptadine